The surge in shares was fueled by the iPhone 17 outselling the iPhone 16 in China and the U.S., according to a report from ...

AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older.

SEPTA is rushing to inspect 225 Silverliner IV rail cars that make up about two-thirds of the Regional Rail fleet following an emergency order from the Federal Railroad Administration. The transit ...

The Trump administration has declared that no federal funding can go toward supplies that “promote or facilitate drug use." ...

The FDA has approved Libtayo for the adjuvant treatment of adult patients with CSCC at high risk of recurrence after surgery and radiation.

Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...

The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.

By: Casey Smith Indiana Capital Chronicle For The Republic After three executions in less than a year — ending a nearly ...

FDA approval based on superiority of Gazyva/Gazyvaro over standard therapy alone, as shown in phase II NOBILITY and phase III REGENCY data1,2Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody ...

President Donald Trump and Australian Prime Minister Anthony Albanese signed a critical-minerals deal at the White House on Monday as the U.S. eyes the continent’s rich ...

Medicare beneficiaries with amyotrophic lateral sclerosis (ALS) were found to have more than 3 times the Medicare expenditures and beneficiary liability of the average Medicare beneficiary.